Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Encompass Health ( (EHC) ) has provided an update.
Encompass Health reported its third-quarter 2025 results, showing a 9.4% increase in net operating revenue to $1,477.5 million compared to the same period last year. The company opened three new hospitals and added 39 beds to existing facilities, reflecting its commitment to expanding capacity and improving patient care. Additionally, Encompass Health increased its full-year guidance, demonstrating confidence in its operational strategy and long-term business prospects.
The most recent analyst rating on (EHC) stock is a Buy with a $150.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.
Spark’s Take on EHC Stock
According to Spark, TipRanks’ AI Analyst, EHC is a Outperform.
Encompass Health’s strong financial performance, particularly in revenue and EBITDA growth, is a major positive factor. The technical indicators support a bullish trend, though caution is advised due to potential overbought conditions. Valuation is moderate, and the earnings call provided a positive outlook despite some operational challenges.
To see Spark’s full report on EHC stock, click here.
More about Encompass Health
Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a presence in 39 states and Puerto Rico. The company provides high-quality rehabilitative care using advanced technology and innovative treatments, and has been recognized as a leader in inpatient rehabilitation by Newsweek and Statista.
Average Trading Volume: 702,699
Technical Sentiment Signal: Buy
Current Market Cap: $12.72B
For an in-depth examination of EHC stock, go to TipRanks’ Overview page.